[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584140":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":11,"locations":19,"responsibleParty":38,"collaborators":11,"id":42,"slug":11,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":11,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":11,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":11,"overallStatus":22,"whyStopped":11,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Al-Azhar University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"platelets rich plasma combined with PDO threads","EXPERIMENTAL",null,[13],"Procedure: platelets rich plasma combined with PDO threads",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":11},"PROCEDURE","1. Injections of platelets-rich plasma in the Anterior Vaginal Wall.\n2. PDO thread placement in the paraurethral, lateral urethrovaginal, and suburethral areas",[9],[20],{"facility":21,"status":22,"city":23,"state":11,"zip":11,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Department of Obstetrics and Gynecology, Faculty of Medicine, Al-Azhar University.","RECRUITING","Cairo","Egypt","EG",{"type":27,"coordinates":28},"Point",[29,30],31.24967,30.06263,{"lat":30,"lon":29},[33],{"name":34,"role":35,"phone":36,"phoneExt":11,"email":37},"Asem Moussa, Professor","CONTACT","+201001414226","dramoussa77@hotmail.com",{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Asem Anwar Moussa","Professor","100584140",false,"NCT06885463","PRP & PDO Threads in Treatment of Stress Incontinence","The Role of Platelets Rich Plasma Combined With PDO Threads in Treatment of Stress Incontinence in Egyptian Women","Inclusion Criteria:\n\n* Nonpregnant Women with SUI\n* Age between 20 to 45 years\n* Patients had a history of failed conservative treatment\n* Patients were on the waiting list for surgical treatment of SUI\n\nExclusion Criteria:\n\n* Under anti-platelet agent treatment\n* Under NSAIDs\n* Platelet dysfunction syndrome\n* Critical thrombocytopenia\n* Hypofibrionogenaemia\n* Sepsis\n* Acute and chronic infections\n* Chronic liver disease\n* Anti-coagulation therapy\n* History of malignancy\n* Pregnancy\n* history of active malignant pathology\n* mental disorders making them unable to give consent\n* genitourinary fistula\n* pelvic organs prolapse stage \\>2 according to the Pelvic Organ Prolapse Quantification system, and detrusor overactivity on urodynamics.","FEMALE","20 Years","45 Years",{"count":52,"type":53},10,"ESTIMATED","INTERVENTIONAL",[56],"NA","The study will include 10 women with pure or predominant SUI symptoms, with severe urodynamic stress incontinence on urodynamics defined as loss of urine with sudden increases in abdominal pressure: eg, coughing, sneezing, or laughing). This will be conducted at the Department of Obstetrics and Gynecology, Faculty of Medicine, Al-Azhar University. The purpose of study is to evaluate the efficacy and safety of platelets rich plasma combined with PDO threads in the treatment of stress incontinence in Egyptian women.",[59],"Stress Incontinence, Female","2025-03-18",{"date":62,"type":63},"2025-03-20","ACTUAL",{"date":65,"type":63},"2025-03-01",{"date":67,"type":53},"2025-06-30",{"name":5,"class":6},1]